SeaStar Medical Holding Corporation (ICU) Q2 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Thank you for standing by. My name is Tina, and I will be your conference operator today. At this time, I would like to welcome everyone to the C-STAR Medical Second Quarter Financial Results Conference Call. All lines have been placed on mute to prevent any background noise. To the speaker's remarks, there will be a question and answer session. To ask a question, simply press star followed by the number one on your telephone keypad. To withdraw your question, press star one again. It is now my pleasure to turn the call over to Jackie Cosman, You may begin. Thank you, Tina. Good afternoon, and thank you for joining the Seastar Medical Second Quarter 2025 Financial Results Conference Call. I'm Jackie Kosman with Wheelhouse Life Science Advisors. Joining me from Seastar Medical today are Eric Schlarf, Chief Executive Officer, David Green, Chief Financial Officer, Dr. Kevin Chung, Chief Medical Officer, and Tim Barachek, Senior Vice President of Commercial and Business Operations. I would like to remind listeners that comments made during this call by management will include forward-looking statements within the meaning of federal securities laws. These forward-looking statements involve risks and uncertainties that could cause actual results to materially differ from any anticipated results. For a list and description of these risks and uncertainties, please review Seastar Medical's filings with the Securities and Exchange Commission. Furthermore, the comments of this conference call contain information that is accurate only as of the date of the live broadcast, August 13, 2025. T-Star Medical undertakes no obligation to revise or update any statements to reflect events or circumstances as required by law. And now, I'll turn the call over to Eric. Eric? Thank you, Jack...